MAUREEN OCONNELL
CIK 1111318 · EVP, CAO & CFO · last filed 2026-03-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.53M
Companies
6
Total Filings
93
Lifetime Open-Market Net
-$19.77M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TEX | Director | 16,351 | $63.80 | $1.04M | $0 | 2 | 2026-03-09 |
| REV Group, Inc. (REVG) Delisted | Director | 2,105 | $63.90 | $134.5K | $0 | 5 | 2026-02-02 |
| ACTG | Director | 272,603 | $4.68 | $1.28M | $94.5K | 9 | 2025-06-03 |
| HHS | Director | 25,414 | $2.53 | $64.2K | $0 | 3 | 2020-09-02 |
| Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Director | 0 | — | — | $0 | 6 | 2018-02-13 |
| SCHL | EVP, CAO & CFO | 71,771 | $43.89 | $3.15M | -$19.86M | 68 | 2017-09-26 |
Recent Filings · Page 10 of 10
93 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-09-06 | SCHL | Grant (A) | — | $0 | EDGAR |
| 2007-04-03 | SCHL | Buy (P) | +25 | $780 | EDGAR |
| 2007-03-22 | SCHL | Grant (A) | — | $0 | EDGAR |
Showing 91–93 of 93
Prev
Page 10 of 10
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.